
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 192 pages)
“Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010-2017”, Diabetes Obes Metab, 2019.
, “What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study”, BMC Med, vol. 17, p. 79, 2019.
, “Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy”, Diabetes Care, vol. 41, pp. 705-712, 2018.
, “Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data”, Diabetes Care, vol. 41, pp. 1844-1853, 2018.
, “Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017”, Diabetes Obes Metab, vol. 20, pp. 2159-2168, 2018.
,